Aljumah M - Search Results

1

Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.

Al Tahan AM, Alsharoqi I, Bohlega SA, Dahdaleh M, Daif A, Deleu D, Esmat K, Giampaolo D, Freedman MS, Gwilt M, Hosny H, Inshasi JS, Aljumah M, Khalifa A, Pakdaman H, Szólics M, Yamout BI, Sahraian MA, Zakaria MF. Al Tahan AM, et al. Among authors: aljumah m. Int J Neurosci. 2014 Sep;124(9):635-41. doi: 10.3109/00207454.2013.865620. Epub 2013 Dec 18. Int J Neurosci. 2014. PMID: 24228830 Review.

2

HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.

Hajeer AH, Sawidan FA, Bohlega S, Saleh S, Sutton P, Shubaili A, Tahan AA, Al Jumah M. Hajeer AH, et al. Int J Immunogenet. 2009 Jun;36(3):169-72. doi: 10.1111/j.1744-313X.2009.00843.x. Int J Immunogenet. 2009. PMID: 19490212

3

Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group.

Yamout BI, Dahdaleh M, Al Jumah MA, Al-Shammri S, Al Sharoqi I, Al-Tahan AR, Bohlega S, Deleu D, Inshasi J, Khalifa A, Szólics M. Yamout BI, et al. Int J Neurosci. 2010 Apr;120(4):273-9. doi: 10.3109/00207450903541087. Int J Neurosci. 2010. PMID: 20374075

4

Familial multiple sclerosis: does consanguinity have a role?

Al Jumah M, Kojan S, Al Khathaami A, Al Abdulkaream I, Al Blawi M, Jawhary A. Al Jumah M, et al. Mult Scler. 2011 Apr;17(4):487-9. doi: 10.1177/1352458510390406. Epub 2010 Dec 21. Mult Scler. 2011. PMID: 21177327

5

Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle East.

Deleu D, Alsharoqi I, Al Jumah MA, Al Tahan AR, Bohlega S, Dahdaleh M, Inshasi J, Khalifa A, Szólics M, Yamout BI. Deleu D, et al. Int J Neurosci. 2011 Apr;121(4):171-5. doi: 10.3109/00207454.2010.541572. Int J Neurosci. 2011. PMID: 21329472 Review.

6

The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group.

Al-Tahan AM, Al-Jumah MA, Bohlega SM, Al-Shammari SN, Al-Sharoqi IA, Dahdaleh MP, Hosny HM, Yamout BI. Al-Tahan AM, et al. Neurosciences (Riyadh). 2011 Apr;16(2):109-13. Neurosciences (Riyadh). 2011. PMID: 21427658

7

Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.

Aljumah M, Alroughani R, Alsharoqi I, Bohlega SA, Dahdaleh M, Deleu D, Esmat K, Khalifa A, Sahraian MA, Szólics M, Altahan A, Yamout BI, Rieckmann P, Daif A. Aljumah M, et al. Mult Scler Int. 2013;2013:952321. doi: 10.1155/2013/952321. Epub 2013 Dec 17. Mult Scler Int. 2013. PMID: 24455267 Free PMC article.

8

Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.

Alroughani RA, Aref HM, Bohlega SA, Dahdaleh MP, Feki I, Al Jumah MA, Al-Kawi MZ, Koussa SF, Sahraian MA, Alsharoqi IA, Yamout BI. Alroughani RA, et al. BMC Neurol. 2014 Feb 12;14:27. doi: 10.1186/1471-2377-14-27. BMC Neurol. 2014. PMID: 24521176 Free PMC article. Review.

9

Functional clinical outcomes in multiple sclerosis: Current status and future prospects.

Karabudak R, Dahdaleh M, Aljumah M, Alroughani R, Alsharoqi IA, AlTahan AM, Bohlega SA, Daif A, Deleu D, Amous A, Inshasi JS, Rieckmann P, Sahraian MA, Yamout BI. Karabudak R, et al. Among authors: aljumah m. Mult Scler Relat Disord. 2015 May;4(3):192-201. doi: 10.1016/j.msard.2015.03.004. Epub 2015 Mar 23. Mult Scler Relat Disord. 2015. PMID: 26008936 Review.

10

Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.

MENA Pompe Working Group; Al Jasmi F, Al Jumah M, Alqarni F, Al-Sanna'a N, Al-Sharif F, Bohlega S, Cupler EJ, Fathalla W, Hamdan MA, Makhseed N, Nafissi S, Nilipour Y, Selim L, Shembesh N, Sunbul R, Tonekaboni SH. MENA Pompe Working Group, et al. BMC Neurol. 2015 Oct 15;15:205. doi: 10.1186/s12883-015-0412-3. BMC Neurol. 2015. PMID: 26471939 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters